Risk Reduction in Peanut Immunotherapy

Benjamin C. Remington, Joseph L. Baumert

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations


Complete avoidance of peanut is difficult and accidental reactions are known to occur. Immunotherapy for peanut allergy is a potential treatment option being developed with the potential to reduce the risk of accidental reactions to peanut in the community. This article covers the epidemiology of unexpected allergic reactions to peanut, and outlines definitions of risk and risk reduction with quantitative risk assessment examples. Well-acknowledged future areas of research still exist, especially in the area of longer-term clinical trials or commercial data, which will strengthen the knowledge surrounding risk and potential options for risk reduction in those with peanut allergy.

Original languageEnglish (US)
Pages (from-to)187-200
Number of pages14
JournalImmunology and Allergy Clinics of North America
Issue number1
StatePublished - Feb 2020


  • Food allergy
  • Peanut
  • Peanut immunotherapy
  • Quantitative risk assessment
  • Quantitative risk reduction
  • Relative risk reduction
  • Risk assessment
  • Risk reduction

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'Risk Reduction in Peanut Immunotherapy'. Together they form a unique fingerprint.

Cite this